Literature DB >> 23604786

Combined grey matter VBM and white matter TBSS analysis in young first episode psychosis patients with and without cannabis consumption.

Sven Haller1, Logos Curtis, Maryse Badan, Séverine Bessero, Mara Albom, Fabrice Chantraine, Alessandro Alimenti, Karl-Olof Lovblad, Panteleimon Giannakopoulos, Marco Merlo.   

Abstract

Cannabis consumption is temporally associated with the development of first episode psychosis (FEP). Whether or not the chronic use of this substance induces structural brain changes that may be responsible for the cognitive and psychological disturbances in this disorder is still matter of debate. To address this issue, we compared the magnetic resonance imaging (MRI)-assessed grey (GM) and white matter (WM) changes in young FEP patients between users versus non-users of cannabis. This prospective study included 50 consecutive FEP subjects: 33 users (22.7 ± 4.1 years, 4 women) and 17 non-users (23.9 ± 4.2 years, 10 women). Users were further divided into 15 heavy (23.3 ± 4.5 years, 2 women) and 18 light users (22.2 ± 3.8 years, 2 women) according to their lifetime cannabis use. Voxel-based-morphometry (VBM) analysis of GM and tract-based-spatial-statistics (TBSS) analysis of WM were performed. Age and gender were used as non-explanatory co-regressors. There were no supra-threshold differences between user and non-user groups for both GM and WM parameters. This was also the case when only heavy users were compared to non-users. Multivariate models controlling for age and gender confirmed these findings. We found no evidence for cannabis consumption related alterations in GM or WM in FEP subjects. Due to the strict correction for multiple comparisons and sample size, we cannot formally exclude subtle morphometric changes associated with cannabis consumption. However, even if present, such potential alterations would be of low magnitude.

Entities:  

Mesh:

Year:  2013        PMID: 23604786     DOI: 10.1007/s10548-013-0288-8

Source DB:  PubMed          Journal:  Brain Topogr        ISSN: 0896-0267            Impact factor:   3.020


  8 in total

1.  Impact of substance use disorder on gray matter volume in schizophrenia.

Authors:  Margaret Quinn; Maureen McHugo; Kristan Armstrong; Neil Woodward; Jennifer Blackford; Stephan Heckers
Journal:  Psychiatry Res Neuroimaging       Date:  2018-08-03       Impact factor: 2.376

Review 2.  Cannabis and Psychosis: a Critical Overview of the Relationship.

Authors:  Charles Ksir; Carl L Hart
Journal:  Curr Psychiatry Rep       Date:  2016-02       Impact factor: 5.285

3.  Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders.

Authors:  Laura Koenders; Marise W J Machielsen; F J van der Meer; Angelique C M van Gasselt; Carin J Meijer; Wim van den Brink; Maarten W J Koeter; Matthan W A Caan; Janna Cousijn; Anouk den Braber; Dennis van 't Ent; Maaike M Rive; Aart H Schene; Elsmarieke van de Giessen; Chaim Huyser; Bart P de Kwaasteniet; Dick J Veltman; Lieuwe de Haan
Journal:  J Psychiatry Neurosci       Date:  2015-05       Impact factor: 6.186

4.  Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants.

Authors:  Sarah D Lichenstein; Nick Manco; Lora M Cope; Leslie Egbo; Kathleen A Garrison; Jillian Hardee; Ansel T Hillmer; Kristen Reeder; Elisa F Stern; Patrick Worhunsky; Sarah W Yip
Journal:  Neuropsychopharmacology       Date:  2021-11-27       Impact factor: 8.294

5.  Linked alterations in gray and white matter morphology in adults with high-functioning autism spectrum disorder: a multimodal brain imaging study.

Authors:  Takashi Itahashi; Takashi Yamada; Motoaki Nakamura; Hiromi Watanabe; Bun Yamagata; Daiki Jimbo; Seiji Shioda; Miho Kuroda; Kazuo Toriizuka; Nobumasa Kato; Ryuichiro Hashimoto
Journal:  Neuroimage Clin       Date:  2014-12-03       Impact factor: 4.881

6.  Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.

Authors:  Musa Basseer Sami; Sagnik Bhattacharyya
Journal:  J Psychopharmacol       Date:  2018-03-29       Impact factor: 4.153

7.  Cannabis use in patients with early psychosis is associated with alterations in putamen and thalamic shape.

Authors:  Musa Sami; James H Cole; Matthew J Kempton; Luciano Annibale; Debasis Das; Marlene Kelbrick; Savitha Eranti; Tracy Collier; Chidimma Onyejiaka; Aisling O'Neill; David J Lythgoe; Philip McGuire; Steve C R Williams; Sagnik Bhattacharyya
Journal:  Hum Brain Mapp       Date:  2020-07-20       Impact factor: 5.399

8.  Effect of high-potency cannabis on corpus callosum microstructure.

Authors:  S Rigucci; T R Marques; M Di Forti; H Taylor; F Dell'Acqua; V Mondelli; S Bonaccorso; A Simmons; A S David; P Girardi; C M Pariante; R M Murray; P Dazzan
Journal:  Psychol Med       Date:  2015-11-27       Impact factor: 10.592

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.